NEWS 2/2/2010 PSTI Receives DSMB Approval to Advance to Final Dose Level PLX-PAD

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

emma

Rank: Treasurer [?]

Points: 16214 [?]

Votes: 82 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

NEWS 2/2/2010 PSTI Receives DSMB Approval to Advance to Final Dose Level PLX-PAD

posted on Mar 03, 2010 07:49AM

Pluristem Therapeutics Receives DSMB Approval to Advance to Final Dose Level With PLX-PAD Buzz up! Print

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply